HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$43.71
Day range
$44.25 - $45.84
Year range
$15.81 - $50.89
Market cap
5.57B USD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Defense World
2 days ago
Barclays Has Lowered Expectations for Guardant Health (NASDAQ:GH) Stock Price
3.01%
0.26%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 201.81M | 30.16% |
Operating expense | 250.95M | 21.30% |
Net income | -111.01M | 40.65% |
Net profit margin | -55.00 | 54.41% |
Earnings per share | -0.62 | 3.13% |
EBITDA | -116.27M | -12.37% |
Effective tax rate | -0.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 839.98M | -28.12% |
Total assets | 1.49B | -16.84% |
Total liabilities | 1.63B | -0.15% |
Total equity | -139.65M | — |
Shares outstanding | 123.42M | — |
Price to book | -38.68 | — |
Return on assets | -20.95% | — |
Return on capital | -25.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -111.01M | 40.65% |
Cash from operations | -64.51M | 18.06% |
Cash from investing | 10.53M | -98.41% |
Cash from financing | -2.94M | -103.24% |
Net change in cash | -58.61M | -108.67% |
Free cash flow | 59.97M | 222.55% |
About
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
2,010
